Robert J. Spiegel - 19 Jan 2023 Form 3 Insider Report for Ayala Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Robert J. Spiegel
Issuer symbol
N/A
Transactions as of
19 Jan 2023
Net transactions value
$0
Form type
3
Filing time
23 Jan 2023, 17:13:21 UTC
Previous filing
17 Jan 2023
Next filing
03 Apr 2023

No securities are beneficially owned.